The prognostic significance of tumor vascular invasion and its association with plasma Epstein-Barr virus DNA, tumor volume and metabolic activity in locoregionally advanced nasopharyngeal carcinoma

Oral Oncology

Volumn 44, Issue 11, 2008, Pages 1067-1072

  Ma, Brigette B Y ^a,c   Mo, Frankie K F ^a   Chan, Anthony T C ^a,c   Hui, Edwin P ^a   Leung, Sing F ^a,c   Lo, Y M Dennis ^a,c   Yau, Yat Y ^b   King, Ann D ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Hong Kong Baptist Hospital   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cavernous sinus invasion; Nasopharyngeal carcinoma; Parapharyngeal invasion

Indexed keywords

CISPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18;

ADVANCED CANCER; ARTICLE; BLOOD SAMPLING; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TUMOR VOLUME;

CAVERNOUS SINUS; COMBINED MODALITY THERAPY; DNA, VIRAL; FEMALE; FLUORODEOXYGLUCOSE F18; HERPESVIRUS 4, HUMAN; HONG KONG; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 53849090287     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.02.001     Document Type: Article

References (26)

1. Ma B.B., and Chan A.T.C. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma. Expert Rev Anticancer Ther 6 (2006) 383-394
2. Chan A.T., Teo P.M., Ngan R.K., Leung T.W., Lau W.H., Zee B., et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20 (2002) 2038-2044
3. Lee A.W., Lau W.H., Tung S.Y., Chua D.T., Chappell R., Xu L., et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol 23 (2005) 6966-6975
4. Teo P., Yu P., Lee W.Y., Leung S.F., Kwan W.H., Yu K.H., et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36 (1996) 291-304
5. Lee A.W., Poon Y.F., Foo W., Law S.C., Cheung F.K., Chan D.K., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23 (1992) 261-270
6. Chan A.T., Lo Y.M., Zee B., Chan L.Y., Ma B.B., Leung S.F., et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 94 (2002) 1614-1619
7. Chua D.T., Sham J.S., Kwong D.L., Choy D.T., Au G.K., and Wu P.M. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis. Cancer 78 (1996) 202-210
8. Ma B.B., King A., Lo Y.M., Yau Y.Y., Zee B., Hui E.P., et al. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 714-720
9. Chang C.C., Liu M.T., and Wu H.K. The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors. Head Neck 24 (2002) 940-946
10. Sze W.M., Yau T.K., Yeung R.M., Lau K.Y., Leung S.K., Hung A.W., et al. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control. Int J Radiat Oncol Biol Phys 59 (2004) 21-27
11. Meng X., Liu S., Li J., Fu Z., Sun X., Yang G., et al. Pretreatment F-18 fluorodeoxyglucose-positron emission tomography standardized uptake value predicts survival after radiation therapy in nasopharyngeal carcinoma. Proc Am Soc Ther Radio Oncol 49th Ann Meeting 69 (2007) S442-S443
12. Sievers K.W., Greess H., Baum U., Dobritz M., and Lenz M. Paranasal sinuses and nasopharynx CT and MRI. Eur J Radiol 33 (2000) 185-202
13. King A.D., Teo P., Lam W.W., Leung S.F., and Metreweli C. Paranasopharyngeal space involvement in nasopharyngeal cancer: detection by CT and MRI. Clin Oncol (R Coll Radiol) 12 (2000) 397-402
14. Teo P., Lee W.Y., and Yu P. The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma. Radiother Oncol 39 (1996) 209-221
15. Cheng S.H., Yen K.L., Jian J.J., Feng A.C., Chan K.Y., Hong C.F., et al. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I-III nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 456-465
16. Chan A.T., Ngan R.K., Teo P.M., Lau W.H., Kwan W.H., Hui E.P., et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 97 (2005) 536-539
17. Teo P., Tsao S.Y., and Leung S.F. After loading intracavitary radiation treatment of nasopharyngeal carcinoma. Description of a technique and preliminary treatment results. Acta Oncol 28 (1989) 525-527
18. Teo P.M., Leung S.F., Fowler J., Leung T.W., Tung Y., Oh S.K., et al. Improved local control for early T-stage nasopharyngeal carcinoma - a tale of two hospitals. Radiother Oncol 57 (2000) 155-166
19. Hui E.P., Ma B.B., Leung S.F., King A., Mo F., Kam M.K., et al. Efficacy of neoadjuvant docetaxel and cisplatin followed by concurrent cisplatin-radiotherapy in locally advanced nasopharyngeal carcinoma (NPC): a randomized phase II study. Proc Am Soc Clin Oncol Ann Meeting 25 18S (2007) A6037
20. Cancer staging handbook from the AJCC cancer staging manual. 6th ed. (2002), Springer-Verlag, New York
21. Yau Y.Y., Chan W.S., Tam Y.M., Vernon P., Wong S., Coel M., et al. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?. J Nucl Med 46 (2005) 283-291
22. Lo Y.M., Chan L.Y., Lo K.W., Leung S.F., Zhang J., Chan A.T., et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 59 (1999) 1188-1191
23. Allal A.S., Kebdani T., Allaoua M., Lehmann W., and Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-d-glucose. Int J Radiat Oncol Biol Phys 59 (2004) 1295-1300
24. Sasaki R., Komaki R., Macapinlac H., Erasmus J., Allen P., Forster K., et al. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23 (2005) 1136-1143
25. Chan K.C., Zhang J., Chan A.T.C., Lei K., Leung S.F., Chan L.Y., et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 63 (2003) 2028-2032
26. Silva J.M., Garcia J.M., Muñoz C., Silva J., Dominguez G., Provencio M., et al. Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells. Gut 50 (2002) 530-534